Skip to main content
Equibles

ALBION FINANCIAL GROUP /UT

Position in A — Agilent Technologies, Inc.

CIK 1054677 SALT LAKE CITY, UT
Back to A Full portfolio

Position in A

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$1,349,552
+$457,545 QoQ
Shares Held
10,160
+29.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#455
of 1,121 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in A Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ALBION FINANCIAL GROUP /UT holds $13,727,883 across 8 Diagnostics & Research names. A ranks #2 (9.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 24,162 $12,113,860
2 A
Agilent Technologies, Inc.
This page 		10,160 $1,349,552
3 DHR
Danaher Corp /De/
 1,290 $245,719
4 IDXX
Idexx Laboratories Inc /De
 21 $11,055
5 WAT
Waters Corp /De/
 15 $5,625
6 LH
Labcorp Holdings Inc.
 6 $1,680
7 ILMN
Illumina, Inc.
 2 $351
8 IMDX
Insight Molecular Diagnostics Inc.
 7 $41

All Filings in A

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,349,552 10,160
2026-03-31 $892,007 7,826
2025-12-31 $1,388,730 10,206
2025-09-30 $1,353,450 10,545
2025-06-30 $1,231,080 10,432
2025-03-31 $1,226,535 10,485
2024-12-31 $1,353,744 10,077
2024-09-30 $1,496,678 10,080
2024-06-30 $1,307,188 10,084
2024-03-31 $1,478,090 10,158
2023-12-31 $1,315,918 9,465
2023-09-30 $1,058,711 9,468
2023-06-30 $964,405 8,020
2023-03-31 $1,307,451 9,451
2022-12-31 $1,395,935 9,328
2022-09-30 $1,098,325 9,036
2022-06-30 $1,007,050 8,479
2022-03-31 $1,116,732 8,439
2021-12-31 $1,345,849 8,430
2021-09-30 $1,316,950 8,360
2021-06-30 $1,223,423 8,277
2020-12-31 $566,145 4,778
2020-09-30 $286,366 2,837
2020-06-30 $211,204 2,390